drug · small molecule
afimetoran
Phase 2updated 5mo agoby Beeline Medicines Corp🔗 ChEMBL
Phase 2community read0 votes
Small molecule drug with a maximum clinical stage of Phase 2 (across all indications), with 2 investigational indications.
indications
indications
Lupus
targets
Toll-like receptor 7Toll-like receptor 8
all catalysts(0)
nothing on the calendar yet
Trials studying afimetoran
- phase2A Study Evaluating the Efficacy and Safety of Afimetoran Compared With Placebo in Participants With Active Systemic Lupus Erythematosus (SLE)
- phase1A Study to Assess the Effect of Famotidine on the Drug Levels of Afimetoran in Healthy Participants
- phase1A Study to Assess the Effect of Phenytoin on the Drug Levels of Afimetoran and the Effect of Afimetoran on the Drug Levels of Midazolam
News(4)
- Beeline Medicines reports promising Phase 2 lupus dataThe business of advancing shelved pharma assets continues to reap benefits, this time for Beeline Medicines and a lupus candidate provided by Bristol Myers Squibb. The buzzy Bain-backed startup sai…endpoints · 19d ago
- Beeline flies into phase 3 as oral lupus drug soars past placeboA phase 2 trial of Beeline Medicines’ afimetoran has hit its primary endpoint, positioning the biotech to swarm into pivotal development in two forms of lupus.fiercebiotech · 19d ago
- These biotechs just landed big fundraising hauls. Here’s what they pitched to investors.Biotechs aimed at eye diseases, autoimmune conditions and longevity medicine have pulled in some of the largest capital raises so far this year.biopharma_dive · 3mo ago
- Beeline ups its Series A round for immune drug workThe company, which was built by Bain Capital, has now raised more than $426 million in its quest to advance a portfolio of Bristol Myers drugs.biopharma_dive · 3mo ago
Data sources
last refreshed 52m ago
Found something off?
comments(0)
5-min edit window · permanent after that